Skip to main content

Advertisement

Log in

What Are We Treating with Chronic Opioid Therapy?

  • CHRONIC PAIN (LJ CROFFORD, SECTION EDITOR)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

The recent increase in the number of patients taking opioids chronically for pain has not yielded the expected benefits in reduction of symptoms and improved function. Chronic pain patients typically respond well initially to opioid medications, but regular use is associated with adverse psychological and physical effects. Patients with significant psychiatric comorbidity and substance use issues are more likely to stay on opioids and to receive higher doses. In the common rheumatological conditions of fibromyalgia and osteoarthritis, opioid treatment is of limited benefit because of lack of efficacy and prominent side effects. Chronic opioid therapy may be more usefully regarded as a form of comfort care, reserved for those patients who have exhausted other treatments and prospects of recovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25:171–86.

    Article  PubMed  CAS  Google Scholar 

  2. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853–60.

    Article  PubMed  CAS  Google Scholar 

  3. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–75.

    Article  PubMed  Google Scholar 

  4. Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol. 2009;28:1419–30.

    Article  PubMed  Google Scholar 

  5. Martin BC, Fan MY, Edlund MJ, et al. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011;26:1450–7.

    Article  PubMed  Google Scholar 

  6. Ballantyne J, Shin N. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24:469–78.

    Article  PubMed  Google Scholar 

  7. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589–94.

    Article  PubMed  Google Scholar 

  8. Turner JA, Franklin G, Fulton-Kehoe D, et al. ISSLS prize winner: early predictors of chronic work disability: a prospective, population-based study of workers with back injuries. Spine (Phila Pa 1976). 2008;33:2809–18.

    Article  Google Scholar 

  9. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19:100–8.

    Article  PubMed  CAS  Google Scholar 

  10. Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am. 2009;91:919–27.

    Google Scholar 

  11. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27:1513–7.

    PubMed  CAS  Google Scholar 

  12. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol. 1999;26:862–9.

    PubMed  CAS  Google Scholar 

  13. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905–15.

    Article  Google Scholar 

  14. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–55.

    Article  PubMed  CAS  Google Scholar 

  15. Nuesch E, Rutjes AW, Husni E, et al: Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009, CD003115.

  16. Ngian GS, Guymer EK, Littlejohn GO. The use of opioids in fibromyalgia. Int J Rheum Dis. 2011;14:6–11.

    Article  PubMed  Google Scholar 

  17. Fitzcharles MA, Ste-Marie PA, Gamsa A, et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med. 2011;124:955–60.

    Article  PubMed  Google Scholar 

  18. • Crofford LJ. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol. 2010;6:191–7. Excellent review of the potential disadvantages of chronic opioid administration.

    Article  PubMed  CAS  Google Scholar 

  19. Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci: Off J Soc Neurosci. 2007;27:10000–6.

    Article  CAS  Google Scholar 

  20. • Edlund MJ, Martin BC, Devries A, et al. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26:1–8. This article clearly delineates the phenomenon of “adverse selection” in opioid treatment.

    Article  PubMed  Google Scholar 

  21. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain: Off J Am Pain Soc. 2009;10:113–30.

    Article  CAS  Google Scholar 

  22. Sullivan MD. Who gets high-dose opioid therapy for chronic non-cancer pain? Pain. 2010;151:567–8.

    Article  PubMed  Google Scholar 

  23. Stein MB, McQuaid JR, Pedrelli P, et al. Posttraumatic stress disorder in the primary care medical setting. Gen Hosp Psychiatry. 2000;22:261–9.

    Article  PubMed  CAS  Google Scholar 

  24. Schwartz AC, Bradley R, Penza KM, et al. Pain medication use among patients with posttraumatic stress disorder. Psychosomatics. 2006;47:136–42.

    Article  PubMed  Google Scholar 

  25. Mills KL, Teesson M, Ross J, et al. The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. Psychiatr Serv. 2005;56:940–5.

    Article  PubMed  Google Scholar 

  26. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307:940–7.

    Article  PubMed  CAS  Google Scholar 

  27. Saunders C. The treatment of intractable pain in terminal cancer. Proc Roy Soc Med. 1963;56:195–7.

    PubMed  CAS  Google Scholar 

  28. Saunders C. A personal therapeutic journey. BMJ. 1996;313:1599–601.

    Article  PubMed  CAS  Google Scholar 

  29. Eisenberger NI. The neural bases of social pain: evidence for shared representations with physical pain. Psychosom Med. 2012;74:126–35.

    Article  PubMed  Google Scholar 

  30. Wasan AD, Butler SF, Budman SH, et al. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23:307–15.

    Article  PubMed  Google Scholar 

  31. • Jamison RN, Edwards RR, Liu X, et al: Relationship of Negative Affect and Outcome of an Opioid Therapy Trial Among Low Back Pain Patients. Pain Pract 2012. Evidence-based examination of the vital role of psychological well-being in pain treatment.

  32. Merlin JS, Childers J, Arnold RM: Chronic Pain in the Outpatient Palliative Care Clinic. The American journal of hospice & palliative care 2012,

  33. Rabow MW, Pantilat SZ, Kerr K, et al. The intersection of need and opportunity: assessing and capitalizing on opportunities to expand hospital-based palliative care services. J Palliat Med. 2010;13:1205–10.

    Article  PubMed  Google Scholar 

  34. Portenoy RK. Appropriate use of opioids for persistent non-cancer pain. Lancet. 2004;364:739–40.

    Article  PubMed  Google Scholar 

  35. Billings JA. What is palliative care? J Palliat Med. 1998;1:73–81.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

Dr Sullivan has served as a consultant for Janssen Pharmaceutica and has received grant support from Pfizer, Covidien, and Endo. Drs Krashin and Ballantyne reported no potential conflicts of interest relevant to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Krashin.

Additional information

This article is part of the Topical Collection on Chronic Pain

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krashin, D., Sullivan, M. & Ballantyne, J. What Are We Treating with Chronic Opioid Therapy?. Curr Rheumatol Rep 15, 311 (2013). https://doi.org/10.1007/s11926-012-0311-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-012-0311-1

Keywords

Navigation